Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto C Boerman

Showing results (131-140 of 319) with videos related to

Pageof 32
Sort By:
Annals of Surgical Oncology|November 24, 2006
Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal originFrits Aarts, Manuel J Koppe, Thijs Hendriks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scannerJonathan A Disselhorst, Maarten Brom, Peter Laverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
A novel facile method of labeling octreotide with (18)F-fluorinePeter Laverman, William J McBride, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal originManuel J Koppe, Robert P Bleichrodt, Annemieke C Soede, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2005
Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposesFrank G van Schaijk, Otto C Boerman, Annemieke C Soede, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for preventionErik Vegt, Marion de Jong, Jack F M Wetzels, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.
Bioconjugate Chemistry|June 23, 2009
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimersCheng-Bin Yim, Otto C Boerman, Monique de Visser, et al.
Contrast Media & Molecular Imaging|April 26, 2014
Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenograftsSusanne Lütje, Catharina M van Rij, Gerben M Franssen, et al.
Nuclear Medicine and Biology|August 21, 2007
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formationHuub J J M Rennen, Peter Laverman, Julliëtte E M van Eerd, et al.
Pageof 32

Showing results (131-140 of 319) with videos related to

Sort By:
Pageof 32
Annals of Surgical Oncology|November 24, 2006
Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal originFrits Aarts, Manuel J Koppe, Thijs Hendriks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scannerJonathan A Disselhorst, Maarten Brom, Peter Laverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
A novel facile method of labeling octreotide with (18)F-fluorinePeter Laverman, William J McBride, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal originManuel J Koppe, Robert P Bleichrodt, Annemieke C Soede, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2005
Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposesFrank G van Schaijk, Otto C Boerman, Annemieke C Soede, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for preventionErik Vegt, Marion de Jong, Jack F M Wetzels, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.
Bioconjugate Chemistry|June 23, 2009
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimersCheng-Bin Yim, Otto C Boerman, Monique de Visser, et al.
Contrast Media & Molecular Imaging|April 26, 2014
Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenograftsSusanne Lütje, Catharina M van Rij, Gerben M Franssen, et al.
Nuclear Medicine and Biology|August 21, 2007
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formationHuub J J M Rennen, Peter Laverman, Julliëtte E M van Eerd, et al.
Pageof 32